BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 22633641)

  • 1. Brown-Vialetto-Van Laere syndrome: a riboflavin-unresponsive patient with a novel mutation in the C20orf54 gene.
    Koy A; Pillekamp F; Hoehn T; Waterham H; Klee D; Mayatepek E; Assmann B
    Pediatr Neurol; 2012 Jun; 46(6):407-9. PubMed ID: 22633641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brown-Vialetto-van Laere syndrome: a riboflavin responsive neuronopathy of infancy with singular features.
    Spagnoli C; Pitt MC; Rahman S; de Sousa C
    Eur J Paediatr Neurol; 2014 Mar; 18(2):231-4. PubMed ID: 24206674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brown-Vialetto-van Laere and Fazio-Londe overlap syndromes: a clinical, biochemical and genetic study.
    Ciccolella M; Catteruccia M; Benedetti S; Moroni I; Uziel G; Pantaleoni C; Chiapparini L; Bizzi A; D'Amico A; Fattori F; Salsano ML; Pastore A; Tozzi G; Piemonte F; Bertini E
    Neuromuscul Disord; 2012 Dec; 22(12):1075-82. PubMed ID: 22824638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four novel C20orf54 mutations identified in Brown-Vialetto-Van Laere syndrome patients.
    Dezfouli MA; Yadegari S; Nafissi S; Elahi E
    J Hum Genet; 2012 Sep; 57(9):613-7. PubMed ID: 22718020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brown-Vialetto-Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment.
    Bosch AM; Abeling NG; Ijlst L; Knoester H; van der Pol WL; Stroomer AE; Wanders RJ; Visser G; Wijburg FA; Duran M; Waterham HR
    J Inherit Metab Dis; 2011 Feb; 34(1):159-64. PubMed ID: 21110228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brown-Vialetto-Van Laere Syndrome as a Mimic of Neuroimmune Disorders: 3 Cases From the Clinic and Review of the Literature.
    Allison T; Roncero I; Forsyth R; Coffman K; Pichon JL
    J Child Neurol; 2017 May; 32(6):528-532. PubMed ID: 28116953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brown-Vialetto-Van Laere syndrome: clinical and neuroradiological findings of a genetically proven patient.
    Bandettini Di Poggio M; Monti Bragadin M; Reni L; Doria-Lamba L; Cereda C; Pardini M; Roccatagliata L; Rossi A; Schenone A
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Mar; 15(1-2):141-4. PubMed ID: 24079556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brown-Vialetto-Van Laere syndrome: a rare syndrome in otology.
    Prabhu HV; Brown MJ
    J Laryngol Otol; 2005 Jun; 119(6):470-2. PubMed ID: 15992475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult onset Brown-Vialetto-Van Laere syndrome with opsoclonus and a novel heterozygous mutation: a case report.
    Cosgrove J; Datta S; Busby M
    Clin Neurol Neurosurg; 2015 Jan; 128():1-3. PubMed ID: 25462087
    [No Abstract]   [Full Text] [Related]  

  • 10. Brown-Vialetto-Van Laere syndrome: clinical and neuropathologic findings with immunohistochemistry for C20orf54 in three affected patients.
    Malafronte P; Clark HB; Castaneda-Sanchez I; Raisanen J; Hatanpaa KJ
    Pediatr Dev Pathol; 2013; 16(5):364-71. PubMed ID: 23688382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early use of high-dose riboflavin in a case of Brown-Vialetto-Van Laere syndrome.
    Anand G; Hasan N; Jayapal S; Huma Z; Ali T; Hull J; Blair E; McShane T; Jayawant S
    Dev Med Child Neurol; 2012 Feb; 54(2):187-9. PubMed ID: 22098162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Case Report of Riboflavin Treatment and Cochlear Implants in a 4-Year-Old Girl with Progressive Hearing Loss and Delayed Speech Development: Brown-Vialetto-Van Laere Syndrome.
    Piecuch AK; Skarżyński PH; Skarżyński H
    Am J Case Rep; 2023 Oct; 24():e940439. PubMed ID: 37786244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brown-Vialetto-Van Laere syndrome: a novel diagnosis to a common presentation.
    Abbas Q; Jafri SK; Ishaque S; Rahman AJ
    BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29950502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brown-Vialetto-Van Laere syndrome: two siblings with a new mutation and dramatic therapeutic effect of high-dose riboflavin.
    Horoz OO; Mungan NO; Yildizdas D; Hergüner Ö; Ceylaner S; Kör D; Waterham H; Coskun T
    J Pediatr Endocrinol Metab; 2016 Feb; 29(2):227-31. PubMed ID: 26444347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The audiovestibular profile of Brown-Vialetto-Van Laere syndrome.
    Omar R; Rajput K; Sirimanna T; Rajput S; Pagarkar W
    J Laryngol Otol; 2021 Nov; 135(11):1000-1009. PubMed ID: 34496984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Riboflavin transporter 3 involvement in infantile Brown-Vialetto-Van Laere disease: two novel mutations.
    Ciccolella M; Corti S; Catteruccia M; Petrini S; Tozzi G; Rizza T; Carrozzo R; Nizzardo M; Bordoni A; Ronchi D; D'Amico A; Rizzo C; Comi GP; Bertini E
    J Med Genet; 2013 Feb; 50(2):104-7. PubMed ID: 23243084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Auditory neuropathy in Brown-Vialetto-Van Laere syndrome due to riboflavin transporter RFVT2 deficiency.
    Menezes MP; O'Brien K; Hill M; Webster R; Antony J; Ouvrier R; Birman C; Gardner-Berry K
    Dev Med Child Neurol; 2016 Aug; 58(8):848-54. PubMed ID: 26918385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brown-Vialetto-Van Laere syndrome and Fazio-Londe disease - treatable motor neuron diseases of childhood.
    Spagnoli C; De Sousa C
    Dev Med Child Neurol; 2012 Apr; 54(4):292-3. PubMed ID: 22211384
    [No Abstract]   [Full Text] [Related]  

  • 19. Brown-Vialetto-Van Laere and Fazio-Londe syndromes: SLC52A3 mutations with puzzling phenotypes and inheritance.
    Gayathri S; Gowda VK; Udhayabanu T; O'Callaghan B; Efthymiou S; Varalakshmi P; Benakappa N; Houlden H; Ashokkumar B
    Eur J Neurol; 2021 Mar; 28(3):945-954. PubMed ID: 33325104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, pathological and functional characterization of riboflavin-responsive neuropathy.
    Manole A; Jaunmuktane Z; Hargreaves I; Ludtmann MHR; Salpietro V; Bello OD; Pope S; Pandraud A; Horga A; Scalco RS; Li A; Ashokkumar B; Lourenço CM; Heales S; Horvath R; Chinnery PF; Toro C; Singleton AB; Jacques TS; Abramov AY; Muntoni F; Hanna MG; Reilly MM; Revesz T; Kullmann DM; Jepson JEC; Houlden H
    Brain; 2017 Nov; 140(11):2820-2837. PubMed ID: 29053833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.